Cari Berget

2.9k citations

55 papers · 1.2k indexed · h-index 20

Impact in

Endocrinology, Diabetes and Metabolism top 1%
- Diabetes Management and Research
- Diabetes Treatment and Management
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Diabetes Management and Education
Genetics top 5%
- Diabetes and associated disorders

Papers in ⓘ

Endocrinology, Diabetes and Metabolism 52
- Diabetes Management and Research 51
- Diabetes Treatment and Management 13
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 7
Speech and Hearing 7
- Adolescent and Pediatric Healthcare 6

Co-authors: Gregory P. Forlenza (31 shared papers)Laurel H. Messer (20 shared papers)Kimberly A. Driscoll (12 shared papers)R. Paul Wadwa (17 shared papers)Laura Pyle (8 shared papers)Tim Vigers (8 shared papers)Jennifer K. Raymond (8 shared papers)John F. Thomas (4 shared papers)
Journals: Diabetes Technology & Therapeutics (11 papers)Diabetes (11 papers)Pediatric Diabetes (6 papers)Diabetes Obesity and Metabolism (3 papers)Journal of Diabetes Science and Technology (2 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

Cari Berget

50 papers receiving 1.2k citations

Peers

Countries citing papers authored by Cari Berget

Since Specialization

Citations

This map shows the geographic impact of Cari Berget's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cari Berget with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cari Berget more than expected).

Fields of papers citing papers by Cari Berget

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cari Berget. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cari Berget. The network helps show where Cari Berget may publish in the future.

Co-authors

The 25 scholars most cited alongside Cari Berget, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cari Berget Line = papers co-authored together Cari Berget links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Real world hybrid closed‐loop discontinuation: Predictors and perceptions of youth discontinuing the 670G system in the first 6 months Pediatric Diabetes ·Laurel H. Messer, Cari Berget, Tim Vigers, Laura Pyle, Cristy Geno, R. Paul Wadwa, Kimberly A. Driscoll, Gregory P. Forlenza	2019	115
2	Six months of hybrid closed loop in the real‐world: An evaluation of children and young adults using the 670G system Pediatric Diabetes ·Cari Berget, Laurel H. Messer, Tim Vigers, Brigitte I. Frohnert, Laura Pyle, R. Paul Wadwa, Kimberly A. Driscoll, Gregory P. Forlenza	2019	98
3	ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Insulin delivery Pediatric Diabetes ·Jennifer L. Sherr, Melissa J. Schoelwer, Tiago Jeronimo Dos Santos, Leenatha Reddy, Torben Biester, Alfonso Galderisi, J C van Dyk, Marisa E. Hilliard, Cari Berget, Linda A. DiMeglio	2022	93
4	A Clinical Overview of Insulin Pump Therapy for the Management of Diabetes: Past, Present, and Future of Intensive Therapy Diabetes Spectrum ·Cari Berget, Laurel H. Messer, Gregory P. Forlenza	2019	85
5	Preserving Skin Integrity with Chronic Device Use in Diabetes Diabetes Technology & Therapeutics ·Laurel H. Messer, Cari Berget, Christie Beatson, Sarit Polsky, Gregory P. Forlenza	2018	80
6	A Clinical Guide to Advanced Diabetes Devices and Closed-Loop Systems Using the CARES Paradigm Diabetes Technology & Therapeutics ·Laurel H. Messer, Cari Berget, Gregory P. Forlenza	2019	65
7	Safety and Performance of the Omnipod Hybrid Closed-Loop System in Adults, Adolescents, and Children with Type 1 Diabetes Over 5 Days Under Free-Living Conditions Diabetes Technology & Therapeutics ·Jennifer L. Sherr, Bruce A. Buckingham, Gregory P. Forlenza, Alfonso Galderisi, Laya Ekhlaspour, R. Paul Wadwa, Lori Carria, Liana Hsu, Cari Berget, Thomas A. Peyser, Joon Bok Lee, JASON B. OCONNOR, Bonnie Dumais, Lauren M. Huyett, Jennifer E. Layne, Trang T. Ly	2019	60
8	CoYoT1 Clinic: Home Telemedicine Increases Young Adult Engagement in Diabetes Care Diabetes Technology & Therapeutics ·Mark W. Reid, Subramanian Krishnan, Cari Berget, Cindy Cain, John F. Thomas, Georgeanna J. Klingensmith, Jennifer K. Raymond	2018	57
9	CoYoT1 Clinic: Innovative Telemedicine Care Model for Young Adults with Type 1 Diabetes Diabetes Technology & Therapeutics ·Jennifer K. Raymond, Cari Berget, Kimberly A. Driscoll, Kaitlin Ketchum, Cynthia Cain, John F. Thomas	2016	56
10	Real-World Use of a New Hybrid Closed Loop Improves Glycemic Control in Youth with Type 1 Diabetes Diabetes Technology & Therapeutics ·Laurel H. Messer, Cari Berget, Laura Pyle, Tim Vigers, Erin Cobry, Kimberly A. Driscoll, Gregory P. Forlenza	2021	52
11	Home Telemedicine (CoYoT1 Clinic): A Novel Approach to Improve Psychosocial Outcomes in Young Adults With Diabetes The Diabetes Educator ·Marwan Bakhach, Mark W. Reid, Elizabeth A. Pyatak, Cari Berget, Cindy Cain, John F. Thomas, Georgeanna J. Klingensmith, Jennifer K. Raymond	2019	46
12	Real-World Evidence of Omnipod ^® 5 Automated Insulin Delivery System Use in 69,902 People with Type 1 Diabetes Diabetes Technology & Therapeutics ·Gregory P. Forlenza, Daniel J. DeSalvo, Grazia Aleppo, Emma G. Wilmot, Cari Berget, Lauren M. Huyett, Irene Hadjiyianni, JOSE J. MENDEZ, Lindsey R. Conroy, Trang T. Ly, Jennifer L. Sherr	2024	36
13	Safety and Performance of the Tandem t:slim X2 with Control-IQ Automated Insulin Delivery System in Toddlers and Preschoolers Diabetes Technology & Therapeutics ·Laya Ekhlaspour, Melissa J. Schoelwer, Gregory P. Forlenza, Mark D. DeBoer, Lisa Norlander, Liana Hsu, Ryan Kingman, Emily Boranian, Cari Berget, Emma Emory, Bruce A. Buckingham, Marc D. Breton, R. Paul Wadwa	2020	35
14	Biopsychosocial Factors Associated With Satisfaction and Sustained Use of Artificial Pancreas Technology and Its Components: a Call to the Technology Field Current Diabetes Reports ·Gregory P. Forlenza, Laurel H. Messer, Cari Berget, R. Paul Wadwa, Kimberly A. Driscoll	2018	35
15	Real‐world performance of hybrid closed loop in youth, young adults, adults and older adults with type 1 diabetes: Identifying a clinical target for hybrid closed‐loop use Diabetes Obesity and Metabolism ·Cari Berget, Halis Kaan Aktürk, Laurel H. Messer, Tim Vigers, Laura Pyle, Janet K. Snell‐Bergeon, Kimberly A. Driscoll, Gregory P. Forlenza	2021	33
16	A Clinical Training Program for Hybrid Closed Loop Therapy in a Pediatric Diabetes Clinic Journal of Diabetes Science and Technology ·Cari Berget, Sarah E. Thomas, Laurel H. Messer, Katelin Thivener, Robert H. Slover, R. Paul Wadwa, G. Todd Alonso	2019	28
17	Review of the Omnipod ^® 5 Automated Glucose Control System Powered by Horizon™ for the Treatment of Type 1 Diabetes Therapeutic Delivery ·Erin Cobry, Cari Berget, Laurel H. Messer, Gregory P. Forlenza	2020	28
18	A Novel Approach to Adolescents With Type 1 Diabetes: The Team Clinic Model Diabetes Spectrum ·Jennifer K. Raymond, Jacqueline J. Shea, Cari Berget, Cindy Cain, Ellen Fay-Itzkowitz, Loise Gilmer, Sandy Hoops, Darcy Owen, Dana Shepard, Gail Spiegel, Georgeanna J. Klingensmith	2015	26
19	Barriers to Uptake of Insulin Technologies and Novel Solutions Medical Devices Evidence and Research ·MEGHAN E. PAULEY, Cari Berget, Laurel H. Messer, Gregory P. Forlenza	2021	24
20	A clinical review of the t:slim X2 insulin pump Expert Opinion on Drug Delivery ·Cari Berget, Samantha Lange, Laurel H. Messer, Gregory P. Forlenza	2020	19

About Cari Berget

Cari Berget is a scholar working on Endocrinology, Diabetes and Metabolism, Speech and Hearing, Surgery, Genetics and Pediatrics, Perinatology and Child Health, having authored 55 papers that have together received 1.2k indexed citations. Recurring topics across this work include Diabetes Management and Research (51 papers), Pancreatic function and diabetes (29 papers), Diabetes and associated disorders (18 papers), Diabetes Treatment and Management (13 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (7 papers), Adolescent and Pediatric Healthcare (6 papers), Childhood Cancer Survivors' Quality of Life (4 papers) and Mobile Health and mHealth Applications (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.1k citations), Genetics (632 citations), Speech and Hearing (125 citations), Surgery (664 citations) and General Health Professions (158 citations). Cari Berget has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Gregory P. Forlenza, Laurel H. Messer, Kimberly A. Driscoll, R. Paul Wadwa, Laura Pyle, Tim Vigers, Jennifer K. Raymond, John F. Thomas, Georgeanna J. Klingensmith and Cindy Cain. Their work appears in journals such as Diabetes Technology & Therapeutics, Diabetes, Pediatric Diabetes, Diabetes Obesity and Metabolism and Journal of Diabetes Science and Technology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact